Objective: The aim of this study is to determine the rate of occurrence and prognosticators of pulmonary Hypertension among patients suffering from Systemic Lupus Erythematosus in our regions. Methodology: This research work was carried out at Rheumatology Department of Allied Hospital, Faisalabad from July 2019 to December 2019. A sum of ninety-seven patients who fulfilled the criteria of ACR (American College of Rheumatology) for systemic lupus erythematosus got recruitment for this research work. The measurement of Pulmonary Arterial Hypertension was carried out with the calculation of the pulmonary arterial SBP (Systolic Blood Pressure) through ECG (Echocardiography) by cardiologist. We collected the characteristics of demography and ...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objective: The aim of this research work is to determine the rate of occurrence and prognosticators ...
Abstract Background No population-based study has investigated the cumulative incidence of pulmonary...
Objectives: This study aims to identify the factors associated with the development and mortality of...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objective: The aim of this research work is to determine the rate of occurrence and prognosticators ...
Abstract Background No population-based study has investigated the cumulative incidence of pulmonary...
Objectives: This study aims to identify the factors associated with the development and mortality of...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...